MKI67 and neoplasm: Moreover, H&E staining and immunohistochemistry analysis of tumor proliferation marker Ki67 further confirmed that the combination of VPRBP silencing and PD-1/PD-L1 checkpoint blockade displayed much potent anti-proliferation effects (Supplementary Fig. 7c, d).